Therefore, to determine which of these events contributed to the oncogenic effects of MTAP-ANRIL, we investigated the MAPK and Akt signaling pathways, which play key roles in tumor proliferation and metastasis. This evidence concerns the gene CDKN2B-AS1 and neoplasm.